Jeffrey A. Bluestone
15Patents
3h-index
29Co-inventors
60Inventor score
Filing activity: Jun 1, 1993 → Sep 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5885573A | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies | Chemistry; Metallurgy | 163 | Expired |
| US6491916B1 | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies | Emerging Cross-Sectional Technologies | 68 | Expired |
| US10138298B2 | Anti-IL-2 antibodies and compositions and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US7722862B2 | Regulatory T cells suppress autoimmunity | Chemistry; Metallurgy | 2 | Active |
| US9801911B2 | Expansion of alloantigen-reactive regulatory T cells | Chemistry; Metallurgy | 2 | Active |
| US9012134B2 | CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs | Physics | 2 | Active |
| US10227290B2 | Glycosphingolipids for use in modulating immune responses | Human Necessities | 1 | Active |
| US9977021B2 | CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs | Physics | 1 | Active |
| US10738113B2 | Anti-IL-2 antibodies and compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12421302B2 | CAR-t cells and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11951136B2 | Preservation of pancreatic islet grafts in the extrahepatic space | Chemistry; Metallurgy | 0 | Active |
| US11459385B2 | Anti-IL-2 antibodies and compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11435349B2 | CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs | Physics | 0 | Active |
| US12103958B2 | Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions | Physics | 0 | Active |
| US9211328B2 | Modulation of NKG2D for prolonging survival of a hematopoietic graft | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.